Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Average Recommendation of “Hold” by Brokerages
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has earned an average rating of “Hold” from the nine research firms that are covering the company, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month price target among […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has earned an average rating of “Hold” from the nine research firms that are covering the company, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month price target among […]
